Fundc2 Regulates Platelet Activation Through Akt/Gsk-3 Beta/Cgmp Axis

Qi Ma,Weilin Zhang,Chongzhuo Zhu,Junling Liu,Quan Chen
DOI: https://doi.org/10.1093/cvr/cvy311
IF: 13.081
2019-01-01
Cardiovascular Research
Abstract:Aims AKT kinase is vital for regulating signal transduction in platelet aggregation. We previously found that mitochondrial protein FUNDC2 mediates phosphoinositide 3-kinase (PI3K)/phosphatidylinositol-3,4,5-trisphosphate (PIP3)-dependent AKT phosphorylation and regulates platelet apoptosis. The aim of this study was to evaluate the role of FUNDC2 in platelet activation and aggregation.Methods and results We demonstrated that FUNDC2 deficiency diminished platelet aggregation in response to a variety of agonists, including adenosine 5'-diphosphate (ADP), collagen, ristocetin/VWF, and thrombin. Consistently, in vivo assays of tail bleeding and thrombus formation showed that FUNDC2-knockout mice displayed deficiency in haemostasis and thrombosis. Mechanistically, FUNDC2 deficiency impairs the phosphorylation of AKT and downstream GSK-3 beta in a PI3K-dependent manner. Moreover, cGMP also plays an important role in FUNDC2/AKT-mediated platelet activation. This FUNDC2/AKT/GSK-3 beta/cGMP axis also regulates clot retraction of platelet-rich plasma.Conclusion FUNDC2 positively regulates platelet functions via AKT/GSK-3 beta/cGMP signalling pathways, which provides new insight for platelet-related diseases.
What problem does this paper attempt to address?